FIELD: medicine, obstetrics.
SUBSTANCE: invention can be used for carrying out prophylaxis of intrauterine infections in children. Method involves seances of enterosorption to pregnant females (from 12 to 23 weeks of pregnancy) with chronic infection form with 2% colloidal chitosan solution with deacetylation degree 0.95, not less, molecular mass 105 Da, in the dose 150 ml, twice per a day, the course dose is 3 l for 20 days. Invention provides reducing titer of specific antibody in mother blood, in particular, IgG that, in turn, prevents damage of tissue structures, in particular, fetus nervous tissue.
EFFECT: improved method for prophylaxis.
5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR RESTORING AND KEEPING FAMILY HEALTH | 2002 |
|
RU2230558C2 |
| METHOD FOR SETTING EARLY STAGE CYTOMEGALOVIRUS INFECTION DIAGNOSIS IN NEWBORNS | 2006 |
|
RU2317550C1 |
| METHOD FOR PREDICTION OF INTRAUTERINE FETAL INFECTION | 2008 |
|
RU2382361C1 |
| METHOD FOR PREDICTION OF RISK OF CONGENITAL INFECTIONS | 2013 |
|
RU2532382C1 |
| METHOD FOR PREDICTING THE CASES OF INTRAUTERINE FETUS INFECTION WITH EPSTEIN-BARR VIRUS | 2004 |
|
RU2276363C2 |
| METHOD FOR FEMALE SCREENING FOR PRENATAL DIAGNOSIS OF CONGENITAL ANOMALIES AND INTRAUTERINE INFECTION OF FOETUS | 2011 |
|
RU2461006C1 |
| METHOD FOR DIAGNOSING INTRAUTERINE VIRAL INFECTION IN BABIES | 2006 |
|
RU2310851C1 |
| METHOD FOR PREDICTION OF ADVERSE PERINATAL OUTCOMES WITH FETAL GROWTH RETARDATION SYNDROME IN WOMEN WITH REACTIVATION OF CHRONIC CYTOMEGALOVIRUS INFECTION IN SECOND TRIMESTER OF PREGNANCY COMPLICATED BY RETROPLACENTARY HEMATOMA | 2016 |
|
RU2648472C1 |
| DIAGNOSTIC TECHNIQUE FOR CONGENITAL VIRAL FOETAL DISEASE | 2019 |
|
RU2728925C1 |
| INTEGRATED MODULE OF FAMILY HEALTH ESTIMATION | 1996 |
|
RU2125829C1 |
